
Servier Pharmaceuticals is an independent, commercial-stage biopharmaceutical company built to think differently about what long-term impact can look like in healthcare. Launched in 2018 and backed by the strength and stability of the Servier Group, our foundation-governed model gives us the freedom to invest for the future, move with purpose, and stay focused on where patients need us most.
In less than a decade, we have grown from a small U.S. presence into a rapidly expanding, multi-billion-dollar organization with an award-winning culture, six commercial products, and a portfolio strengthened through bold strategic investments and innovation. Our teams are helping advance important new treatment options for patients facing serious diseases with high unmet need, particularly in rare oncology and neurology.
Our ambition is clear: to build a leading U.S. biopharmaceutical company known for scientific excellence, operational strength, and deep commitment to patients. Just as important is how we build it. We are creating a culture that values entrepreneurship, collaboration, accountability, and the belief that individuals at every level can shape the future of the company.
For people who want more than a job — who want the opportunity to build, lead, grow, and make a measurable impact — Servier offers the chance to be part of a company with purpose, momentum, and the ability to help define what comes next for patients and for our industry.
Under the guidance of the Director, Field Medical Lead for Hematology & Oncology, the Medical Science Liaison (MSL) is responsible for managing and executing field medical activities within a specific geographic territory and contributing to company-wide initiatives that support Servier’s strategy. The MSL will serve as a critical link between Servier and external healthcare providers (HCPs) establishing strong professional collaborations with investigators and other HCPs within the designated territory. Focusing on hematology & oncology (AML, MDS, ALL, CCA), the MSL will provide credible scientific expertise within Servier and share scientific insights that will impact the strategies of U.S and Global Medical teams, Servier’s Leadership Team, and other internal stakeholders. The MSL’s actions and collaborations with HCP’s are on the forefront of advancing science and medicine on behalf of patients.
Servier is committed to modeling diversity, equity, and inclusion within the industry. We are dedicated to fostering an environment that maintains equitable treatment for all and we welcome applicants who are passionate, committed, and innovative individuals. We encourage candidates to apply to our open roles as we are always willing to consider experiences and skills beyond what is listed in the job description.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
The salary range for this role is $170,000-$195,000. An employee’s pay position within the salary range will be based on several factors including, but not limited to, relevant education, qualifications, certifications, experience, skills, geographic location, performance, and business or organizational needs. We may ultimately pay more or less than the posted range, and the range may be modified in the future. Employees in this position are also eligible for Short-Term and Long-Term incentive programs. Servier also offers a competitive and comprehensive benefits package that includes benefits such as medical, dental, vision, flexible time off (Servier provides unlimited sick time and flex time, and does not accrue time off), 401(k), life and disability insurance, recognition programs among other great benefits (all benefits are subject to eligibility requirements).

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle.
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D.
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion.
--
To report a suspected adverse event with a Servier drug, please visit servier.com